
Defense Contractors Move to Drop Anthropic AI After Trump Administration Ban
Mar 04, 2026 01:30 am UTC| Politics Governance Business Technology
Major U.S. defense contractors are expected to remove Anthropics AI tools from their supply chains following a directive from the Trump administration, even though legal experts say the ban could face serious challenges in...

Blackstone’s BCRED Fund Sees $1.7B Net Outflows as Private Credit Concerns Shake Investors
Mar 04, 2026 01:25 am UTC| Business
Blackstones flagship private credit vehicle, Blackstone Private Credit Fund (BCRED), experienced significant withdrawal pressure during the first quarter as investor sentiment toward the rapidly expanding private credit...

FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Mar 04, 2026 01:16 am UTC| Business Health Governance
The U.S. Food and Drug Administration (FDA) has issued a warning to Danish pharmaceutical giant Novo Nordisk regarding a consumer advertisement for its widely used diabetes drug, Ozempic. According to the regulator, the ad...

OpenAI Explores New Code-Hosting Platform to Reduce Dependence on GitHub
Mar 04, 2026 01:10 am UTC| Business Technology
OpenAI is reportedly developing a new code-hosting platform that could eventually compete with Microsofts GitHub, according to a recent report citing sources familiar with the initiative. The project is still in its early...

Santander’s $12.2B Webster Financial Deal Faces Uncertainty Amid U.S.–Spain Trade Tensions
Mar 04, 2026 01:09 am UTC| Business Politics
Banco Santanders proposed $12.2 billion acquisition of U.S. regional lender Webster Financial may face delays following comments from President Donald Trump suggesting a halt in trade with Spain. According to Wells Fargo...

Middle East Air War Triggers Massive Flight Cancellations and Global Airline Disruptions
Mar 04, 2026 01:06 am UTC| Business Politics
The escalating U.S. and Israeli air war against Iran has created major disruptions across the global aviation and tourism industries, forcing airlines and governments to manage the fallout as tens of thousands of travelers...

Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Mar 04, 2026 01:01 am UTC| Business Health Law
Moderna has reached a major legal settlement worth up to $2.25 billion with Genevant Sciences and Arbutus Biopharma, ending a long-running patent dispute over the lipid nanoparticle (LNP) technology used in its COVID-19...